Versor Investments’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18,900	Closed	-$489K	–	429
2025 Q4	$489K	Buy	+18,900	New	+$449K	0.08%	338
2024 Q1	–	Sell	-12,692	Closed	-$428K	–	839
2023 Q4	$428K	Buy	12,692 +4,397	+53%	+$129K	0.09%	386
2023 Q3	$254K	Sell	8,295 -4,474	-35%	-$161K	0.05%	528
2023 Q2	$512K	Sell	12,769 -1,075	-8%	-$44.4K	0.09%	252
2023 Q1	$565K	Sell	13,844 -2,203	-14%	-$87.6K	0.07%	283
2022 Q4	$620K	Buy	+16,047	New	+$781K	0.05%	277
2022 Q3	–	Sell	-4,200	Closed	-$245K	–	909
2022 Q2	$245K	Buy	+4,200	New	+$275K	0.01%	692
2020 Q2	–	Sell	-14,732	Closed	-$494K	–	273
2020 Q1	$494K	Buy	+14,732	New	+$612K	0.03%	114